Close Menu

NHS

The software tool, currently in development, is set to be introduced next year and could also find application in other indications such as cancer.

In Nature this week: population sequencing led to rare disease diagnoses, analysis of marine green alga leads to discovery of new phylum, and more.

Because of coronavirus-related shutdowns of customer labs, the San Diego-based firm saw decreased revenues in all geographic regions, especially outside the US.

Balancing the Two

The Economist reports on an approach used by UK researchers to study medical records while protecting patient privacy.

Illumina will sequence 35,000 whole genomes for the Genetics of Mortality in Critical Care (GenOMICC) study and will provide an in-kind contribution.

The partners aim to identify signatures to predict the severity of disease in those infected and determine how patients will respond to therapies.

Following its Path

The UK is launching a research consortium to sequence SARS-CoV-2 samples from patients.

The consortium, which spans more than a dozen UK cities, will sequence patient samples to understand the spread and evolution of the novel coronavirus.

The deal provides whole-genome sequencing for patients with rare diseases or cancer and could make sequencing part of the standard of care for NHS England.

To Find the Cause

The National Health Service in England has begun to sequence the exomes of critically ill infants and children, the Telegraph reports.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.